When People say Sell? Should you Buy? Yes
According to what happened to HGSI, ACOR, DNDN, todays next big Biotech could be JAZZ ' First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
HGSI, ACOR, DNDN all were below $5 stocks prior to rallying over 500%-1000%.
Here is the catch: Analysts put sell ratings on the stocks prior to Phase Data being released, saying the odds for success were low and I actually remember DNDN when it was $7 when an Analyst put a sell rating on it with a $1 target causing the stock to fall 25% on the day. The very next day data came out and the stock soared into the $20's. Funny thing is it happened again with ACOR yesterday.